Related Experiment Video
Updated: Aug 19, 2026
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
Reducing mortality in sepsis: new directions
Jean-Louis Vincent1, Edward Abraham, Djillali Annane
1Department of Intensive Care, Erasme Hospital (Free University of Brussels), Brussels, Belgium. jlvincen@ulb.ac.be
Abstract:
Considerable progress has been made in the past few years in the development of therapeutic interventions that can reduce mortality in sepsis. However, encouraging physicians to put the results of new studies into practice is not always simple. A roundtable was thus convened to provide guidance for clinicians on the integration and implementation of new interventions into the intensive care unit (ICU). Five topics were selected that have been shown in randomized, controlled trials to reduce mortality: limiting the tidal volume in acute lung injury or acute respiratory distress syndrome, early goal-directed therapy, use of drotrecogin alfa (activated), use of moderate doses of steroids, and tight control of blood sugar. One of the principal investigators for each study was invited to participate in the roundtable. The discussions and questions that followed the presentation of data by each panel member enabled a consensus recommendation to be derived regarding when each intervention should be used. Each new intervention has a place in the management of patients with sepsis. Furthermore, and importantly, the therapies are not mutually exclusive; many patients will need a combination of several approaches--an "ICU package". The present article provides guidelines from experts in the field on optimal patient selection and timing for each intervention, and provides advice on how to integrate new therapies into ICU practice, including protocol development, so that mortality rates from this disease process can be reduced.
Insights
Implementing evidence-based interventions like low tidal volume ventilation and early goal-directed therapy can significantly reduce sepsis mortality. This guidance helps clinicians integrate these life-saving strategies into intensive care units.
Area of Science:
- Critical Care Medicine
- Pulmonology
- Endocrinology
Background:
- Sepsis remains a leading cause of mortality, necessitating improved clinical practices.
- Translating research findings on sepsis interventions into routine clinical care presents challenges.
Purpose of the Study:
- To provide expert guidance on integrating evidence-based sepsis interventions into intensive care unit (ICU) practice.
- To facilitate the adoption of strategies shown to reduce sepsis-related mortality.
Main Methods:
- A roundtable discussion with principal investigators of key sepsis mortality-reducing studies.
- Consensus development on optimal patient selection and timing for interventions.
Main Results:
- Five key interventions proven to reduce sepsis mortality were discussed: low tidal volume ventilation for acute lung injury/acute respiratory distress syndrome, early goal-directed therapy, drotrecogin alfa (activated), moderate-dose steroids, and tight glycemic control.
- Recommendations were derived for the appropriate use of each intervention.
- The synergistic effect of combining multiple interventions (an "ICU package") was emphasized.
Conclusions:
- Individual interventions have a defined role in sepsis management.
- A combination of therapies is often required for optimal sepsis care.
- Guidelines are provided for integrating these interventions into ICU protocols to decrease mortality.
